摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[4-(三氟甲氧基)胺]乙酸乙酯 | 306935-79-5

中文名称
2-[4-(三氟甲氧基)胺]乙酸乙酯
中文别名
——
英文名称
ethyl (4-(trifluoromethoxy)phenyl)glycinate
英文别名
Ethyl 2-[4-(trifluoromethoxy)anilino]acetate
2-[4-(三氟甲氧基)胺]乙酸乙酯化学式
CAS
306935-79-5
化学式
C11H12F3NO3
mdl
MFCD00176763
分子量
263.216
InChiKey
FNHJUHOZXLJSJE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    86-89°C
  • 溶解度:
    7.2 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    7

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2922509090

SDS

SDS:5be52b400b17a9396555f77296be7bee
查看
Name: Ethyl 2-[4-(trifluoromethoxy)anilino]acetate 97% Material Safety Data Sheet
Synonym: N-(4-Trifluoromethoxyphenyl)glycine ethyl este
CAS: 306935-79-5
Section 1 - Chemical Product MSDS Name:Ethyl 2-[4-(trifluoromethoxy)anilino]acetate 97% Material Safety Data Sheet
Synonym:N-(4-Trifluoromethoxyphenyl)glycine ethyl este

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
306935-79-5 Ethyl 2-[4-(trifluoromethoxy)anilino]a 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 306935-79-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 86 - 89 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H12F3NO3
Molecular Weight: 263

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 306935-79-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl 2-[4-(trifluoromethoxy)anilino]acetate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 306935-79-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 306935-79-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 306935-79-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

乙基(4-三氟甲氧基苯基)甘氨酸是甘氨酸(HY-Y0966)的衍生物。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[4-(三氟甲氧基)胺]乙酸乙酯 、 sodium hydroxide 作用下, 以 四氢呋喃乙醇 为溶剂, 生成 4-(trifluoromethoxy)phenylglycine
    参考文献:
    名称:
    通过光诱导脱芳构化构建桥联苯并氮杂卓
    摘要:
    开发了一种温和有效的方案,通过光催化脱芳构化将简单的芳香族底物转化为增值且结构复杂的桥联苯并氮杂卓。可通过碱促进或光诱导的分子内氢氨化的操作来提供可切换的非对映选择性。
    DOI:
    10.1002/anie.202314304
  • 作为产物:
    参考文献:
    名称:
    通过自由基环化-极性加成级联电合成高功能化喹啉
    摘要:
    通过N-芳基甘氨酸盐和亚甲基环丙烷之间的电化学交叉脱氢偶联说明了多种官能化的喹啉-2-羧酸盐的合成。在这些不含过渡金属和氧化剂的温和电化学条件下,各种不同的功能具有良好的兼容性,从而有助于广泛的底物范围和实际适用性。循环伏安测量和对照实验表明,涉及自由基中间体的正式[4 + 2]环加成反应,然后通过亲核极性加成打开环丙基环,连续形成C-C和C-N键。
    DOI:
    10.1021/acs.orglett.4c02470
点击查看最新优质反应信息

文献信息

  • [EN] CASPASE 6 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE CASPASE 6 ET LEURS UTILISATIONS
    申请人:UNIV CALIFORNIA
    公开号:WO2021102361A1
    公开(公告)日:2021-05-27
    Disclosed herein, inter alia, are compounds and methods for inhibiting Caspase 6 and the treatment of diseases, pharmaceutical composition including a compound as described herein and a pharmaceutically acceptable excipient and methods of inhibiting human Caspase 6 protein activity, the method including: contacting the human Caspase 6 protein with a compound as described herein.
    本公开的内容包括抑制Caspase 6和治疗疾病的化合物和方法,包括一种如上所述的化合物和药用可接受的赋形剂的药物组合物,以及抑制人类Caspase 6蛋白活性的方法,该方法包括:将人类Caspase 6蛋白与如上所述的化合物接触。
  • 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
    申请人:Aspnes Gary E.
    公开号:US20100197591A1
    公开(公告)日:2010-08-05
    The invention provides compounds of the general Formula (I) where R 1 , R 2 , and A are defined herein, as well as the preparation, compositions and uses thereof.
    这项发明提供了一般式(I)的化合物 其中R1、R2和A在此处定义,以及其制备、组成和用途。
  • [EN] FERROCHELATASE INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE FERROCHELATASE ET PROCÉDÉS D'UTILISATION
    申请人:UNIV INDIANA RES & TECH CORP
    公开号:WO2019213076A1
    公开(公告)日:2019-11-07
    The invention relates to a method of treatment of a patient with a ferrochelatase inhibitor, or a pharmaceutically acceptable salt thereof, or a derivative thereof. Also, the invention relates to a method of treatment of a patient with a ferrochelatase inhibitor that is a triazolopyrimidinone, or a derivative thereof, or a pharmaceutically acceptable salt thereof.
    这项发明涉及一种使用铁螯合酶抑制剂或其药用盐或衍生物治疗患者的方法。此外,该发明涉及一种使用三唑吡咯啉酮类铁螯合酶抑制剂或其衍生物或药用盐治疗患者的方法。
  • Facile Synthetic Methods for Diverse <i>N</i>-Arylphenylalanine Derivatives via Transformations of Aryne Intermediates and Cross-Coupling Reactions
    作者:Tsuneyuki Kobayashi、Takamitsu Hosoya、Suguru Yoshida
    DOI:10.1246/bcsj.20210149
    日期:2021.7.15
    transformations of N-arylphenylalanine ester-type platforms is disclosed. The highly functionalized platforms were prepared by an oxidative cross-coupling reaction leaving aryne generating moieties and halogeno groups intact. Great transformability of N-arylphenylalanine ester-type platforms by aryne reactions and cross-coupling reactions allowed us to prepare analogs of bioactive compounds.
    公开了通过N-芳基苯基丙氨酸酯型平台的顺序转化来合成各种N-芳基苯基丙氨酸衍生物。通过氧化交叉偶联反应制备高度官能化的平台,使芳烃生成部分和卤代基团完整保留。N-芳基苯丙氨酸酯型平台通过芳烃反应和交叉偶联反应的巨大可转化性使我们能够制备生物活性化合物的类似物。
  • Aryne Reaction and Cross-coupling Approach for the Synthesis of Diverse <i>N</i>-Arylphenylalanine Derivatives
    作者:Tsuneyuki Kobayashi、Takamitsu Hosoya、Suguru Yoshida
    DOI:10.1246/cl.200276
    日期:2020.7.5
    A facile synthesis of diverse N-arylphenylalanine derivatives is described. We have developed an efficient method for preparing diverse N-arylphenylalanine ester-type platforms containing an aryne ...
    描述了多种 N-芳基苯丙氨酸衍生物的简便合成。我们开发了一种有效的方法来制备含有芳烃的多种 N-芳基苯丙氨酸酯型平台...
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物